EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

导出原文传递

翻译打印收藏纠错

作者： Daria Handkiewicz-Junak ^[1] ; Thorsten D. Poeppel ^[2] ; Lisa Bodei ^[3] ; Cumali Aktolun ^[4] ; Samer Ezziddin ^[5] ; Francesco Giammarile ^[6] ; Roberto C. Delgado-Bolton ^[7] ; Michael Gabriel ^[8]

作者单位： Nuclear Medicine, University Hospital USK, Saarland University ^[1] Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency (IAEA) ^[2] Clinic for Nuclear Medicine, University Hospital Essen ^[3] Department of Radiology, Memorial Sloan Kettering Cancer Center ^[4] Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro ^[5] Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska Curie Memorial Cancer Center ^[6] Institute of Nuclear Medicine and Endocrinology, Kepler University Hospital ^[7] Tirocenter Nuclear Medicine Center ^[8]

关键词 Radionuclide therapy Bone metastases Beta-emitting radionuclides Strontium-89 Samarium-153 Phosphorus-32 Efficacy

发布时间 2018-12-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交